MDT · News · 20261019N

Management Changes

Medtronic plc · 2026-10-19 · Importance 34 · Surprise 42 · No source text

Medtronic appointed Michael Marinaro as president effective October 14, 2026. He will retain his existing responsibilities and add oversight of the company’s Greater China operations. His compensation package includes a $1.0 million increased base salary, a target annual incentive, and approximately $3.25 million in supplemental long-term incentive awards.

Key facts

• The most recent consensus estimate called for Medtronic quarterly revenue of $9.47 billion, up 5.66% from the year-ago period. source
• Michael Marinaro's compensation includes an increased base salary of $1,000,000 and supplemental long-term incentive awards totaling approximately $3.25 million (in addition to a target annual incentive). source
• First Bank & Trust increased its stake in Medtronic PLC by 43.6% in the third quarter, acquiring an additional 10,881 shares to bring its total holdings to 35,848 shares valued at $3.09 million. source
• Medtronic appointed Michael Marinaro as its new President, effective October 14, 2026. source
• Analysts expect Medtronic to post earnings of $1.34 per share, which would mark a year-over-year decline of 1.47%. source
• Michael Marinaro will retain his previous responsibilities and also oversee the company's Greater China operations. source
• The patient featured in the InterStim therapy story was compensated by Medtronic. source
• Medtronic's shares had gained 2.84% over the past month, outpacing the Medical sector's gain of 1.97% and the S&P 500's gain of 1.46%. source

Impact estimates